Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guy A Higgins

Showing results (51-60 of 78) with videos related to

Pageof 8
Sort By:
Psychopharmacology|February 27, 2004
Pharmacological and genetic evidence indicates that combined inhibition of NR2A and NR2B subunit containing NMDA receptors is required to disrupt prepulse inhibitionWill Spooren, Cedric Mombereau, Martine Maco, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 23, 2011
The 5-HT2C receptor agonist lorcaserin reduces nicotine self-administration, discrimination, and reinstatement: relationship to feeding behavior and impulse controlGuy A Higgins, Leo B Silenieks, Anne Rossmann, et al.
ACS Chemical Neuroscience|May 15, 2019
Evaluation of Selective 5-HT<sub>2C</sub> Agonists in Acute Seizure ModelsLeonardo B Silenieks, Nicole K Carroll, Annalise Van Niekerk, et al.
Pharmacology, Biochemistry, and Behavior|April 14, 2012
Rolapitant (SCH 619734): a potent, selective and orally active neurokinin NK1 receptor antagonist with centrally-mediated antiemetic effects in ferretsRuth A Duffy, Cynthia Morgan, Robert Naylor, et al.
Neuroscience|January 6, 2024
Effect of a single psilocybin treatment on Fos protein expression in male rat brainDouglas Funk, Joseph Araujo, Malik Slassi, et al.
Behavioural Brain Research|August 21, 2007
The effect of caffeine to increase reaction time in the rat during a test of attention is mediated through antagonism of adenosine A2A receptorsGuy A Higgins, Michael E Grzelak, Annamarie J Pond, et al.
Neuropharmacology|February 21, 2012
Effects of the 5-HT2C receptor agonist Ro60-0175 and the 5-HT2A receptor antagonist M100907 on nicotine self-administration and reinstatementPaul J Fletcher, Zoë Rizos, Kevin Noble, et al.
European Journal of Pharmacology|October 13, 2009
The anti-epileptic drug lacosamide (Vimpat) has anxiolytic property in rodentsGuy A Higgins, Nathalie Breysse, Elijus Undzys, et al.
Frontiers in Pharmacology|May 12, 2020
Characterization of Amphetamine, Methylphenidate, Nicotine, and Atomoxetine on Measures of Attention, Impulsive Action, and Motivation in the Rat: Implications for Translational ResearchGuy A Higgins, Leo B Silenieks, Cam MacMillan, et al.
Bioorganic & Medicinal Chemistry Letters|June 29, 2005
2-(2-Furanyl)-7-phenyl[1,2,4]triazolo[1,5-c]pyrimidin-5-amine analogs as adenosine A2A antagonists: the successful reduction of hERG activity. Part 2Julius J Matasi, John P Caldwell, Hongtao Zhang, et al.
Pageof 8

Showing results (51-60 of 78) with videos related to

Sort By:
Pageof 8
Psychopharmacology|February 27, 2004
Pharmacological and genetic evidence indicates that combined inhibition of NR2A and NR2B subunit containing NMDA receptors is required to disrupt prepulse inhibitionWill Spooren, Cedric Mombereau, Martine Maco, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 23, 2011
The 5-HT2C receptor agonist lorcaserin reduces nicotine self-administration, discrimination, and reinstatement: relationship to feeding behavior and impulse controlGuy A Higgins, Leo B Silenieks, Anne Rossmann, et al.
ACS Chemical Neuroscience|May 15, 2019
Evaluation of Selective 5-HT<sub>2C</sub> Agonists in Acute Seizure ModelsLeonardo B Silenieks, Nicole K Carroll, Annalise Van Niekerk, et al.
Pharmacology, Biochemistry, and Behavior|April 14, 2012
Rolapitant (SCH 619734): a potent, selective and orally active neurokinin NK1 receptor antagonist with centrally-mediated antiemetic effects in ferretsRuth A Duffy, Cynthia Morgan, Robert Naylor, et al.
Neuroscience|January 6, 2024
Effect of a single psilocybin treatment on Fos protein expression in male rat brainDouglas Funk, Joseph Araujo, Malik Slassi, et al.
Behavioural Brain Research|August 21, 2007
The effect of caffeine to increase reaction time in the rat during a test of attention is mediated through antagonism of adenosine A2A receptorsGuy A Higgins, Michael E Grzelak, Annamarie J Pond, et al.
Neuropharmacology|February 21, 2012
Effects of the 5-HT2C receptor agonist Ro60-0175 and the 5-HT2A receptor antagonist M100907 on nicotine self-administration and reinstatementPaul J Fletcher, Zoë Rizos, Kevin Noble, et al.
European Journal of Pharmacology|October 13, 2009
The anti-epileptic drug lacosamide (Vimpat) has anxiolytic property in rodentsGuy A Higgins, Nathalie Breysse, Elijus Undzys, et al.
Frontiers in Pharmacology|May 12, 2020
Characterization of Amphetamine, Methylphenidate, Nicotine, and Atomoxetine on Measures of Attention, Impulsive Action, and Motivation in the Rat: Implications for Translational ResearchGuy A Higgins, Leo B Silenieks, Cam MacMillan, et al.
Bioorganic & Medicinal Chemistry Letters|June 29, 2005
2-(2-Furanyl)-7-phenyl[1,2,4]triazolo[1,5-c]pyrimidin-5-amine analogs as adenosine A2A antagonists: the successful reduction of hERG activity. Part 2Julius J Matasi, John P Caldwell, Hongtao Zhang, et al.
Pageof 8